VANLENT ANNE 4

4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Dec 6, 2019

Insider Transaction Report

Form 4
Period: 2019-12-04
VANLENT ANNE
Director
Transactions
  • Award

    Stock Option (right to buy)

    2019-12-04+10,00010,000 total
    Exercise: $3.02Exp: 2029-12-04Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable on December 4, 2020.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT